A Randomized Controlled Trial of Aliskiren in the Prevention of Major Cardiovascular Events in Elderly People.
Phase of Trial: Phase III
Latest Information Update: 24 Aug 2016
At a glance
- Drugs Aliskiren (Primary) ; Amlodipine; Hydrochlorothiazide
- Indications Cardiovascular disorders; Hypertension
- Focus Registrational; Therapeutic Use
- Acronyms APOLLO
- Sponsors Novartis
- 19 Jul 2013 Status changed from active, no longer recruiting to discontinued.
- 17 Jun 2013 Results presented at the 23rd European Meeting on Hypertension.
- 27 Oct 2012 Planned number of patients changed from 1758 to 11000 as reported by European Clinical Trials Database record.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History